Haldol, Haldol Decanoate (haloperidol) dosing, indications, interactions, adverse effects, and more
Blonanserin versus haloperidol in Japanese patients with schizophrenia: A phase 3, 8‐week, double‐blind, multicenter, randomized controlled study - Harvey - 2019 - Neuropsychopharmacology Reports - Wiley Online Library
JCM | Free Full-Text | How to Manage Withdrawal of Sedation and Analgesia in Mechanically Ventilated COVID-19 Patients?
Haloperidol Oral Solution USP (Concentrate) 2 mg mL Rx ONLY
Time to retire haloperidol? | MDedge Psychiatry
Co-Occurring Conditions: Agitation, Medical Comorbidities, and Anxiety Disorders (Node 1) - Psychopharmacology Institute
Social anxiety disorder - Wikipedia
The Use of Rapid Tranquilization in Aggressive Behavior (28.06.2019)
Understanding Haloperidol | Emergency Physicians Monthly
SPECT studies of D2 occupancy in low-dose haloperidol treatment
Haloperidol in palliative care: Indications and risks - ScienceDirect
Delirium - EMCrit Project
Indications and dosing recommendations for haloperidol. | Download Scientific Diagram
Relationship between the dose of haloperidol and D 2 occupancy: (A)... | Download Scientific Diagram
Comparison of the Intravenous Haloperidol and Diazepam on Recovery from Conversion Disorders in Emergency Ward Patients: Double Blind, Randomized Clinical Trial of Efficacy and Safety | Semantic Scholar
Palliative Care in the Emergency Department: Simplified Symptomatic Management - GEDC
Long-acting injectable antipsychotics: What to do about missed doses | MDedge Psychiatry
Common Otolaryngologic Medications: Psychiatric Side Effects
Parkinson's Disease: Low-Dose Haloperidol Increases Dopamine Receptor Sensitivity and Clinical Response
Antipsychotic Withdrawal Syndrome - Understanding the Hyperbolic Curve and Tapering Antipsychotic Treatment to Reduce the Risk of Relapse
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis - The Lancet
A Comparison of Risperidone and Haloperidol for the Prevention of Relapse in Patients with Schizophrenia | NEJM
Schizophrenia in adults: Maintenance therapy and side effect management - UpToDate
Haloperidol in palliative care: Indications and risks - ScienceDirect
Frontiers | Propionate Protects Haloperidol-Induced Neurite Lesions Mediated by Neuropeptide Y
